|
|
(31 intermediate revisions not shown) |
Line 2: |
Line 2: |
| dir="ltr" lang="en-US"> | | dir="ltr" lang="en-US"> |
| <head> | | <head> |
| + | |
| + | |
| <meta http-equiv="Content-Type" | | <meta http-equiv="Content-Type" |
| content="text/html; charset=UTF-8" /> | | content="text/html; charset=UTF-8" /> |
| <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7" /> | | <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7" /> |
- | <title>FREiGEM</title> | + | <title>Artisteer</title> |
| <script type="text/javascript" src="script.js"></script> | | <script type="text/javascript" src="script.js"></script> |
- | <link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style.css&action=raw&ctype=text/css" | + | <link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style.css&action=raw&ctype=text/css |
| + | " |
| type="text/css" media="screen" /> | | type="text/css" media="screen" /> |
- | <!--[if IE 6]><link rel="stylesheet" href="style.ie6.css" type="text/css" media="screen" /><![endif]--><!--[if IE 7]><link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style_ie7.css&action=raw&ctype=text/css" type="text/css" media="screen" /><![endif]--> | + | <!--[if IE 6]><link rel="stylesheet" href="style.ie6.css" type="text/css" media="screen" /><![endif]--><!--[if IE 7]><link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style_ie7.css&action=raw&ctype=text/css |
| + | " type="text/css" media="screen" /><![endif]--> |
| </head> | | </head> |
| <body> | | <body> |
Line 32: |
Line 36: |
| <div class="r"></div> | | <div class="r"></div> |
| <ul class="art-menu"> | | <ul class="art-menu"> |
- | <li><a href="https://2009.igem.org/Team:Freiburg_bioware" | + | <li><a href="https://2009.igem.org/Team:Freiburg_bioware"><span |
- | class="active"><span class="l"></span><span
| + | class="l"></span><span class="r"></span><span |
- | class="r"></span><span class="t">Home</span></a></li>
| + | class="t">Home</span></a></li> |
| <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team"><span | | <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team"><span |
| class="l"></span><span class="r"></span><span | | class="l"></span><span class="r"></span><span |
Line 46: |
Line 50: |
| </li> | | </li> |
| <li><a | | <li><a |
- | href="https://2009.igem.org/Team:Freiburg_bioware/Project"><span | + | href="https://2009.igem.org/Team:Freiburg_bioware/Project" |
- | class="l"></span><span class="r"></span><span
| + | class="active"><span class="l"></span><span |
- | class="t">The
| + | class="r"></span><span class="t">The |
| Project</span></a> | | Project</span></a> |
| <ul> | | <ul> |
Line 54: |
Line 58: |
| href="https://2009.igem.org/Team:Freiburg_bioware/Project#Summary">Summary</a> | | href="https://2009.igem.org/Team:Freiburg_bioware/Project#Summary">Summary</a> |
| </li> | | </li> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/Project#Subprojects">Subprojects</a></li> |
| <li><a | | <li><a |
| href="https://2009.igem.org/Team:Freiburg_bioware/Project#Highlights">Highlights</a></li> | | href="https://2009.igem.org/Team:Freiburg_bioware/Project#Highlights">Highlights</a></li> |
Line 113: |
Line 119: |
| <div class="art-Post-inner"> | | <div class="art-Post-inner"> |
| <div class="art-PostMetadataHeader"> | | <div class="art-PostMetadataHeader"> |
- | <h2 class="art-PostHeaderIcon-wrapper"> <img | + | <h2 class="art-PostHeaderIcon-wrapper"> <img |
- | style="width: 28px; height: 25px;" alt=""
| + | src="https://static.igem.org/mediawiki/2009/2/2a/Freiburg09_Post_tanne_2.png" alt="PostHeaderIcon" |
- | src="https://static.igem.org/mediawiki/2009/2/2a/Freiburg09_Post_tanne_2.png" /> | + | height="25" width="26" /> <i>in vivo</i> assay</h2> |
- | In vivo assays<span class="art-PostHeader"></span> </h2>
| + | |
| </div> | | </div> |
- | <p class="MsoNormal" style="line-height: normal;"><b><span | + | <div class="art-PostContent"> <br /> |
- | style="font-size: 12pt; font-family: "Lucida Sans","sans-serif";"
| + | <span style="font-weight: bold;"></span> |
- | lang="EN-US"></span></b></p>
| + | <table style="text-align: left; width: 627px; height: 261px;" |
- | <table | + | border="0" cellpadding="0" cellspacing="0"> |
- | style="width: 900px; text-align: left; margin-left: auto; margin-right: auto;"
| + | <tbody bgcolor="#e2eff9"> |
- | border="0" cellpadding="2" cellspacing="2"> | + | |
- | <tbody> | + | |
| <tr align="center"> | | <tr align="center"> |
- | <td><img style="width: 400px; height: 216px;" | + | <td><img style="width: 300px; height: 225px;" |
| alt="" | | alt="" |
- | src="https://static.igem.org/mediawiki/2009/1/1c/Freiburg09_17-10-09_Phagenplatten_XGal.JPG" /></td> | + | src="https://static.igem.org/mediawiki/2009/thumb/9/9a/Freiburg_09_2009-09-21_multidimensional_RV308_electro_mit_fluo_oligos-4_c1.JPG/800px-Freiburg_09_2009-09-21_multidimensional_RV308_electro_mit_fluo_oligos-4_c1.JPG" /></td> |
| </tr> | | </tr> |
| <tr align="center"> | | <tr align="center"> |
- | <td><span | + | <td>Fluorescence microscope image of RV308 cells, |
- | style="font-size: 10pt; line-height: 115%; font-family: "Times New Roman","serif";"
| + | electroporated with fluorescein labeled oligonucleotides </td> |
- | lang="EN-US">ER2738
| + | |
- | and XL1 blue infected by entire phages</span></td>
| + | |
| </tr> | | </tr> |
| </tbody> | | </tbody> |
| </table> | | </table> |
- | <p class="MsoNormal" style="line-height: normal;"><b><span
| + | <span style="font-weight: bold;"></span><br /> |
- | style="font-size: 12pt; font-family: "Lucida Sans","sans-serif";"
| + | <h3>Introduction</h3> |
- | lang="EN-US"></span></b></p>
| + | |
- | <p class="MsoNormal" style="line-height: normal;"><b><span | + | |
- | style="font-size: 12pt; font-family: "Lucida Sans","sans-serif";"
| + | |
- | lang="EN-US">Introduction</span></b><span
| + | |
- | style="font-size: 12pt; font-family: "Lucida Sans","sans-serif";"
| + | |
- | lang="EN-US"><br />
| + | |
| In vivo use of programmable restriction enzymes can provide the | | In vivo use of programmable restriction enzymes can provide the |
- | opportunity of | + | opportunity of genome engineering. Here we develop and test strategies |
- | genome engineering. Here we develop and test strategies for the | + | for the application of our programmable restriction endonuclease.<br /> |
- | application of | + | <br /> |
- | our programmable restriction endonuclease. <o:p></o:p></span></p> | + | In our strategy we cotransformed Fok_i and Fok_a constructs fused to |
- | <p class="MsoNormal" style="line-height: normal;"><span
| + | binding domains into a certain bacteria strain leading to the basal |
- | style="font-size: 12pt; font-family: "Lucida Sans","sans-serif";"
| + | |
- | lang="EN-US">In our strategy we cotransformed Fok_i and
| + | |
- | Fok_a constructs | + | |
- | fused to binding domains into a certain bacteria strain leading to the | + | |
- | basal | + | |
| expression of the Fok heterodimers. Transformation of single-stranded | | expression of the Fok heterodimers. Transformation of single-stranded |
| bacteriophage M13 DNA hybridized with modified oligonucleotides enables | | bacteriophage M13 DNA hybridized with modified oligonucleotides enables |
- | the Fok | + | the Fok heterodimers to bind the DNA. Inside the cells the phage DNA |
- | heterodimers to bind the DNA. Inside the cells the phage DNA should be | + | should be cut by the dimerized and thereby activated Fok_a should |
- | cut by | + | result in a decreased progeny of phages within the bacterial culture in |
- | the dimerized and thereby activated Fok_a should result in a decreased | + | comparison to control assays. Two ways of detection were envisioned. A |
- | progeny | + | qPCR should reveal successful cutting of the phage DNA by the lack of |
- | of phages within the bacterial culture in comparison to control assays. | + | amplified phage DNA. In addition an adjacent phage titer determination |
- | Two | + | via a blue white screening ressembling phage assay by plating the cells |
- | ways of detection were envisioned. A qPCR should reveal successful | + | to IPTG/Xgal plates should lead to a decreased number of plaques in |
- | cutting of | + | comparison to the control assays. <br /> |
- | the phage DNA by the lack of amplified phage DNA. In addition an | + | <br /> |
- | adjacent phage | + | <table style="text-align: left; width: 322px; height: 436px;" |
- | titer determination via blue white screening <span style=""> </span>by | + | border="0" cellpadding="0" cellspacing="0"> |
- | plating the cells to IPTG/Xgal plates for | + | <tbody bgcolor="#e2eff9"> |
- | an adjacent phage titer determination via blue white screening should
| + | <tr align="center"> |
- | lead to a | + | <td><img style="width: 300px; height: 400px;" |
- | decreased number of plaques in comparison to the control assays. <o:p></o:p></span></p> | + | alt="" |
- | <p class="MsoNormal" style="line-height: normal;"><b | + | src="https://static.igem.org/mediawiki/2009/b/b4/Freiburg09_In.vivo.assay.scheme.png" /></td> |
- | style=""><span | + | </tr> |
- | style="font-size: 12pt; font-family: "Lucida Sans","sans-serif";"
| + | <tr align="center"> |
- | lang="EN-US">Methods<o:p></o:p></span></b></p> | + | <td>in vivo scheme</td> |
- | <h1><span | + | </tr> |
- | style="font-size: 12pt; line-height: 115%; font-family: "Lucida Sans","sans-serif"; color: windowtext; font-weight: normal;"
| + | </tbody> |
- | lang="EN-US">In detail two heterodimeric Fok constructs
| + | </table> |
- | His-Dig-Split-Fok_a (</span><span | + | <br /> |
- | style="font-size: 12pt; line-height: 115%; font-family: "Lucida Sans","sans-serif"; color: windowtext; font-weight: normal;"
| + | <br /> |
- | lang="EN-US">BBa_K243036</span><span
| + | <h3>Methods</h3> |
- | style="font-size: 12pt; line-height: 115%; font-family: "Lucida Sans","sans-serif"; color: windowtext; font-weight: normal;"
| + | In detail two heterodimeric Fok constructs His-Dig-Split-Fok_a |
- | lang="EN-US">) and
| + | (BBa_K243036) and His-FluA-Split-Fok_i (BBa_K243010) are encoded by two |
- | His-FluA-Split-Fok_i (</span><span | + | different plasmids, plasmid pJS419 with a chloramphenicol and pEx with |
- | style="font-size: 12pt; line-height: 115%; font-family: "Lucida Sans","sans-serif"; color: windowtext; font-weight: normal;"
| + | an ampicillin resistance. This enables a positive selection of the |
- | lang="EN-US">BBa_K243010)</span><span
| + | bacteria strain XL1 blue cotransformed with both plasmids. Subsequent |
- | style="font-size: 12pt; line-height: 115%; font-family: "Lucida Sans","sans-serif"; color: windowtext; font-weight: normal;"
| + | to the preparation of electrocompetent cotransformed XL1 blue, the M13 |
- | lang="EN-US"> are encoded by two different
| + | ssDNA hybridized with the modified oligonucleotides were inserted into |
- | plasmids, plasmid pJS419 with a chloramphenicol and pEx with an | + | these bacteria by electroporation at 1.7 kV. The infected cells were |
- | ampicillin | + | incubated at 37°C for 0.5 h. At different dilutions the phages |
- | resistance. This enables a positive selection of the bacteria strain | + | were mixed with 180μl ER2738 cells with an OD600 of about 0.5. |
- | XL1 blue | + | Then they were mixed with 3 ml of 42°C warm top agar and plated |
- | cotransformed with both plasmids. Subsequent to the preparation of | + | on IPTG/X-Gal plates.<br /> |
- | electrocompetent | + | <br /> |
- | cotransformed XL1 blue, the M13 ssDNA hybridized with the modified | + | XL1 Blue as well as ER2738 harbour a F-plasmid coding for the |
- | oligonucleotides were inserted into these bacteria by electroporation | + | omega-fragment of beta-galactosidase. The M13 phages in turn encodes |
- | at 1.7 | + | |
- | kV. The infected cells were incubated at 37°C for 1.5 h. At | + | |
- | different dilutions | + | |
- | the phages were mixed with 180</span><span | + | |
- | style="font-size: 12pt; line-height: 115%; font-family: "Times New Roman","serif"; color: windowtext; font-weight: normal;">μ</span><span
| + | |
- | style="font-size: 12pt; line-height: 115%; font-family: "Lucida Sans","sans-serif"; color: windowtext; font-weight: normal;"
| + | |
- | lang="EN-US">l ER2738
| + | |
- | cells with an OD600 of about 0.5. After an incubation time of 10 | + | |
- | minutes they
| + | |
- | were plated in 3 ml top agar on IPTG/X-Gal plates. </span><span | + | |
- | style="font-size: 12pt; line-height: 115%; font-family: "Lucida Sans","sans-serif"; color: windowtext; font-weight: normal;"
| + | |
- | lang="EN-US"><o:p></o:p></span></h1>
| + | |
- | <p class="MsoNormal" style="line-height: normal;"><span
| + | |
- | style="font-size: 12pt; font-family: "Lucida Sans","sans-serif";"
| + | |
- | lang="EN-US">XL1 Blue as well as ER2738 harbour a F-plasmid
| + | |
- | coding | + | |
- | for the omega-fragment of beta-galactosidase. The M13 phages in turn | + | |
- | encodes | + | |
| the lacking alpha-fragment. Consequently, alpha-complementation can be | | the lacking alpha-fragment. Consequently, alpha-complementation can be |
- | detected | + | detected via a screening for blue plaques. After incubation overnight |
- | by a blue/white screening. After incubation overnight at 37°C
| + | at 37°C the infected cells were inspected for blue plaques |
- | the infected | + | formation because of the enzymatic cleavage of X-Gal and production of |
- | cells were inspected for blue plaques fomration because of the | + | the blue dye 5,5'-dibromine-4,4'-dichloride-indigo and plaques can be |
- | enzymatic | + | seen where the phages lysed the XL1 blue cells. In comparison with |
- | cleavage of X-Gal and production of the blue dye | + | plated bacteria only transformed with M13 ssDNA, M13 ssDNA with other |
- | 5,5'-dibromine-4,4'-dichloride-indigo and plaques can be seen where the | + | oligos not modified or infected with entire phages directly the number |
- | phages | + | of pfu (plaque forming units) should be decreased.<br /> |
- | lysed the ER2738 cells. In comparison with plated bacteria only | + | <br /> |
- | transformed | + | Another possible approach is a qPCR after the insertion and incubation |
- | with M13 ssDNA, M13 ssDNA with other oligos not modified or infected | + | of the phage DNA hybridized with a modified oligo or pure ssDNA into |
- | with | + | the XL1 blue. This quantitative real time polymerase chain reaction |
- | entire phages directly the number of pfu (plaque forming units) should | + | allows to amplify and simultaneously quantify a certain sequence of the |
- | be | + | phage DNA. The additional feature of the qPCR is the quantification of |
- | decreased.<o:p></o:p></span></p> | + | the accumulating DNA happens in real time after each amplification |
- | <p class="MsoNormal" style="line-height: normal;"><span
| + | step. The phage DNA would be extracted by boiling preparation, a method |
- | style="font-size: 12pt; font-family: "Lucida Sans","sans-serif";"
| + | faster than conventional alkaline lysis minipreps leaving the DNA |
- | lang="EN-US">Another possible approach is a qPCR after the
| + | somewhat dirtier, but adequate for qPCR. After the qPCR with |
- | insertion and incubation of the phage DNA hybridized with a modified | + | appropriate primers, the DNA can be quantified with a fluorescent dye, |
- | oligo or | + | intercalating in the double-stranded DNA. The expected result would be |
- | pure ssDNA into the XL1 blue. This quantitative real time polymerase | + | a lower amount of double-stranded phage DNA for our XL1 blue |
- | chain | + | transformed with DNA and oligo in comparison to the control assay.<br /> |
- | reaction allows to amplify and simultaneously quantify a certain
| + | <br /> |
- | sequence of | + | <br /> |
- | the phage DNA. The additional feature of the qPCR is the quantification
| + | <h3>Results and Discussion</h3> |
- | of the
| + | Our attempt to plate cotransformated XL1 Blue on IPTG/X-Gal plates |
- | accumulating DNA happens in real time after each amplification step. | + | showed several blue plaques for the M13 DNA without hybridized |
- | The phage | + | oligonucleotides. In comparison the M13 DNA hybridized with the |
- | DNA would be extracted by boiling preparation, a method faster than | + | modified oligonucleotide showed no blue plaques, demonstrating that the |
- | conventional alkaline lysis minipreps leaving the DNA somewhat dirtier, | + | binding of the basally expressed heterodimeric Fok constructs triggered |
- | but | + | by the labeled guide oligonucleotides and the following cleavage of the |
- | adequate for qPCR. After the qPCR with appropriate primers, the DNA can | + | phage DNA was successful and the progeny of the phages and thus |
- | be quantified | + | alpha/complementation decreased.<br /> |
- | with a fluorescent dye, intercalating in the double-stranded DNA. The | + | <br /> |
- | expected | + | <table style="text-align: left; width: 464px; height: 272px;" |
- | result would be a lower amount of double-stranded phage DNA for our XL1 | + | border="0" cellpadding="0" cellspacing="0"> |
- | blue | + | <tbody bgcolor="#e2eff9"> |
- | transformed with DNA and oligo in comparison to the control assay.<o:p></o:p></span></p> | + | <tr> |
- | <p class="MsoNormal" style="line-height: normal;"><b | + | <td><img style="width: 450px; height: 220px;" |
- | style=""><span
| + | alt="" |
- | style="font-size: 12pt; font-family: "Lucida Sans","sans-serif";"
| + | src="https://static.igem.org/mediawiki/2009/e/ee/Freiburg09_plaques_plates_P1000313.jpg" /></td> |
- | lang="EN-US">Results and Discussion<o:p></o:p></span></b></p> | + | </tr> |
- | <p class="MsoNormal" style="line-height: normal;"><span
| + | <tr> |
- | style="font-size: 12pt; font-family: "Lucida Sans","sans-serif";" | + | <td>M13 DNA without (left) and with (right) hybridized |
- | lang="EN-US">After the first test attempt to plate | + | modified oligonucleotide, no plaques formation in presence of modified |
- | cotransformated
| + | oligonucleotide</td> |
- | XL1 Blue on IPTG/X-Gal plates no blue plaques could be seen, indicating
| + | </tr> |
- | that we
| + | </tbody> |
- | plated the wrong dilutions, the M13 ssDNA wasn’t good, our
| + | </table> |
- | cells aren’t
| + | <br /> |
- | electrocompetent or the basal activity of Fok_a and Fok_i is already
| + | The qPCR assay is still in progress. Expected results have still to be |
- | sufficient
| + | verified. |
- | to destroy the whole phage DNA without an adapter-oligo. A
| + | <p><span class="art-button-wrapper"></span></p> |
- | transformation of a
| + | <p><span class="art-button-wrapper"><br /> |
- | test plasmid in the electrocompetent XL1 blue and another
| + | </span></p> |
- | electrocompetent
| + | <br /> |
- | strain, RV 308, showed in comparison a weaker but existing
| + | </div> |
- | transformation rate
| + | |
- | in XL1 blue. Another test assay was to test our infection method by
| + | |
- | infecton of
| + | |
- | ER2738 and XL1 blue with phages from the ph.d 7 phage display peptide
| + | |
- | library,
| + | |
- | i.e. incubation of cells with OD600 of about 0.5 at different phage
| + | |
- | dilutions
| + | |
- | and plating them in prewarmed top agar on IPTG/X-Gal plates. Only the
| + | |
- | ER2738
| + | |
- | but not XL1 blue showed entire blue coloration of the plates.
| + | |
- | (Bedeutung für
| + | |
- | Xblue?) At another test assay we transformed the XL1 blue with new M13
| + | |
- | ssDNA
| + | |
- | and incubated them for 1.5h on a 37°C shaker at 750rpm. Then we
| + | |
- | mixed them at
| + | |
- | different concentrations with ER2738 of an OD600 of 0.42 and plated
| + | |
- | them after
| + | |
- | 10 min incubation time in top agar on IPTG/X-Gal plates. As result all
| + | |
- | the
| + | |
- | plates were totally blue. Also with a shorter incubation time of XL1
| + | |
- | blue of
| + | |
- | 0.5h on the 37°C shaker we obtained the same result indicating
| + | |
- | that our ER2738
| + | |
- | are already contaminated with phages. Now the next is to try the
| + | |
- | boiling prep
| + | |
- | and the qPCR or redo the same assay with new ER2738.<o:p></o:p></span></p>
| + | |
- | <p class="MsoNormal" style="line-height: normal;"><span | + | |
- | style="font-size: 12pt; font-family: "Lucida Sans","sans-serif";"
| + | |
- | lang="EN-US"><small></small><o:p></o:p></span></p>
| + | |
| <div class="cleared"></div> | | <div class="cleared"></div> |
| </div> | | </div> |
| </div> | | </div> |
| </div> | | </div> |
- | <b><br /> | + | <div class="art-Post"> |
- | </b></div> | + | <div class="art-Post-inner"><br /> |
| + | <div class="art-PostContent"><br /> |
| + | <br /> |
| + | <p> <span class="art-button-wrapper"> </span></p> |
| + | </div> |
| + | </div> |
| + | <div class="art-Post-body"> |
| + | </div> |
| + | </div> |
| + | </div> |
| </div> | | </div> |
| <div class="cleared"></div> | | <div class="cleared"></div> |
Line 316: |
Line 268: |
| <div class="art-Footer-inner"> | | <div class="art-Footer-inner"> |
| <div class="art-Footer-text"> | | <div class="art-Footer-text"> |
- | <p><b>contact: <a | + | <p>contact: <a |
| href="mailto:freigem09@googlemail.com">freigem09@googlemail.com</a><br /> | | href="mailto:freigem09@googlemail.com">freigem09@googlemail.com</a><br /> |
- | </b></p>
| + | </p> |
| </div> | | </div> |
| </div> | | </div> |
Line 325: |
Line 277: |
| </div> | | </div> |
| </div> | | </div> |
| + | <p class="art-page-footer"><a |
| + | href="http://www.artisteer.com/">Web Template</a> |
| + | created with Artisteer.</p> |
| </div> | | </div> |
| </body> | | </body> |
| </html> | | </html> |